How Corpay is cashing in on expenses
Financial technology company Corpay has found a profitable niche managing corporate payments


One of the problems with operating in a fastgrowing industry is that constant change and disruption can make it hard to remain successful. No sooner has a company developed a business model that is profitable than the technology shifts or competition pushes down prices. This causes margins or market share to tumble, since large amounts of investment are required to stay ahead of the competition.
So it’s often better to find a niche that is big enough to be worthwhile, but not so big as to attract a lot of other firms.
Financial technology company Corpay (NYSE: CPAY) has done just that. The firm specialises in corporate payments, including travel and hotel expenses as well as general vendor payments. These can be a nightmare for companies to manage, as giving too much latitude to employees can result in wasteful (or even fraudulent) spending.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Yet on the other hand, micro-managing employees’ spending can sometimes backfire, increasing the need for outlay on administration, not to mention the risk of missing opportunities.
Corpay is keeping it simple
Corpay has developed several solutions that allow firms to keep things as simple as possible, while still ensuring that money is spent efficiently and companies can change their payments policy quickly. These solutions include automated systems as well as pre-paid cards.
Another touted benefit of Corpay’s offering is that it can function as a one-stop shop for business payments, eliminating the need to give employees cards from separate companies to deal with different types of payments.
This ambitious strategy has been a big hit with many businesses, as shown by the fact that Corpay’s revenue has grown by an average of around 15% a year since 2010.
Even though growth has slowed a bit in recent years, Corpay still managed to increase sales by around 50% between 2019 and 2024. It expects to keep growing, helped by plans to launch a service that can make it easier for firms to handle cross-border payments in multiple countries.
Margins remain strong with a consistent operating margin of over 40% and a return on capital employed of just under 20%. With last year’s earnings of $14.2 per share projected to rise 73% over the next two years, thanks to the effect of acquisitions and strong growth in the US and Brazil, Corpay trades at a relatively modest 14 times the consensus forecast for 2026.
As well as a business that is profitable and growing, Corpay’s shares seem to have a good amount of momentum behind them: they have gone up by 40% over the past nine months. They have also outperformed the rest of the US market over the last six months and trade above both their 50-day and 200-day moving averages.
I would therefore suggest that you go long at the current price of $368 at £8 per $1. You should also put the stop loss at $245, which gives you a total downside of £984.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Are UK Reits the most unloved asset?
Recent updates from UK Reits are looking more positive, but the market remains entirely unimpressed
By Cris Sholto Heaton Published
-
Side hustle tax changes: HMRC reforms could save thousands from filing self-assessment tax returns
The government plans to raise the tax-free threshold for trading income – here is how it could help your side hustle
By Marc Shoffman Published
-
Drone company Red Cat Holdings sees shares tumble
Red Cat, the unprofitable and inefficient US drone manufacturer is set to slide
By Dr Matthew Partridge Published
-
Why Sezzle's shares may be overvalued
Sezzle, the US buy-now-pay-later provider, is resting on shaky foundations. Is it time to sell this stock?
By Dr Matthew Partridge Published
-
MoneyWeek's trading tips - how did they fare in 2024?
My tips have yielded a profit and the open positions are proving lucrative, too
By Dr Matthew Partridge Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Harworth doubles profit as revenue soars – should you buy?
Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
By Dr Matthew Partridge Published
-
Bitcoin miner Riot Platforms bleeds money – what happens now?
Riot Platforms struggles to make a profit and looks absurdly overvalued. Are troubles brewing?
By Dr Matthew Partridge Published
-
M&S recovery has momentum: will it stick?
After years of decline, M&S seems to have turned a corner. But is this just a “dead cat bounce”?
By Dr Matthew Partridge Published
-
Is Alpha Group a good buy?
Alpha Group helps clients manage risks such as foreign exchange. After being promoted to the London Stock Exchange, does the stock still rally?
By Dr Matthew Partridge Published